Oral administration of Lactobacillus delbrueckii subspecies bulgaricus OLL1073R-1 suppresses inflammation by decreasing interleukin-6 responses in a murine model of atopic dermatitis

Journal of Dairy Science

Volumn 96, Issue 6, 2013, Pages 3525-3534

  Kano, Hiroshi ^a   Kita, Junko ^a   Makino, Seiya ^a   Ikegami, Shuji ^a   Itoh, Hiroyuki ^a  

^a MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

Atopic dermatitis; Interleukin 6; Lactobacillus delbrueckii ssp. bulgaricus; Serum amyloid A

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN 130, HUMAN; HYBRID PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; INTERLEUKIN 6;

ANIMAL; ARTICLE; ATOPIC DERMATITIS; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; DRUG EFFECT; FEMALE; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; INFLAMMATION; LACTOBACILLUS DELBRUECKII; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; FEMALE; GLYCOPROTEINS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKIN-6; LACTOBACILLUS DELBRUECKII; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS;

ACARI; ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; MURINAE; MUS;

EID: 84878107118     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-6514     Document Type: Article

References (29)

1. Bunikowski R., Gerhold K., Bräutigam M., Hamelmann E., Renz H., Wahn U. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int. Arch. Allergy Immunol. 2001, 125:344-348.
2. Chambers R.E., Hutton C.W., Dieppe P.A., Whicher J.T. Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation. Ann. Rheum. Dis. 1991, 50:677-679.
3. Chiba Y., Shida K., Nagata S., Wada M., Bian L., Wang C., Shimizu T., Yamashiro Y., Kiyoshima-Shibata J., Nanno M., Nomoto K. Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei. Immunology 2010, 130:352-362.
4. + Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest 2005, 115:313-325.
5. Ganapathi M.K., May L.T., Schultz D., Brabenec A., Weinstein J., Sehgal P.B., Kushner I. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem. Biophys. Res. Commun. 1988, 157:271-277.
6. Goodman W.A., Levine A.D., Massari J.V., Sugiyama H., McCormick T.S., Cooper K.D. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J. Immunol. 2009, 183:3170-3176.
7. Han Y., Kim B., Ban J., Lee J., Kim B.J., Choi B.S., Hwang S., Ahn K., Kim J. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr. Allergy Immunol. 2012, 23:667-673.
8. Hasegawa T., Hirakawa K., Matsumoto T., Toki S., Maeyama Y., Morimatsu F. Efficacy of Lactobacillus plantarum strain HSK201 in relief from Japanese cedar pollinosis. Biosci. Biotechnol. Biochem. 2009, 73:2626-2631.
9. Ishihara K., Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002, 13:357-368.
10. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001, 357:1076-1079.
11. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361:1869-1871.
12. Kano H., Kaneko T., Kaminogawa S. Oral intake of Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J. Food Prot. 2002, 65:153-160. a.
13. Kano H., Mogami O., Uchida M. Oral administration of milk fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 to DBA/1 mice inhibits secretion of proinflammatory cytokines. Cytotechnology 2002, 40:67-73. b.
14. Lee C.E., Neuland M.E., Teaford H.G., Villacis B.F., Dixon P.S., Valtier S., Yeh C.H., Fournier D.C., Charlesworth E.N. Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. J. Allergy Clin. Immunol. 1992, 89:1010-1020.
15. Masuda Y., Takahashi T., Yoshida K., Nishitani Y., Mizuno M., Mizoguchi H. Anti-allergic effect of lactic acid bacteria isolated from seed mash used for brewing sake is not dependent on the total IgE levels. J. Biosci. Bioeng. 2012, 114:292-296.
16. Park S.J., Nakagawa T., Kitamura H., Atsumi T., Kamon H., Sawa S., Kamimura D., Ueda N., Iwakura Y., Ishihara K., Murakami M., Hirano T. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 2004, 173:3844-3854.
17. Rincon M. Interleukin-6: From an inflammatory marker to a target for inflammatory diseases. Trends Immunol. 2012, 33:571-577.
18. Samochocki Z., Alifier M., Bodera P., Jeziorkowska R., Rosiak E., Jurkiewicz B., Glińska O., Gliński W., Stankiewicz W. T-regulatory cells in severe atopic dermatitis: Alterations related to cytokines and other lymphocyte subpopulations. Arch. Dermatol. Res. 2012, 304:795-801.
19. Sano S., Chan K.S., Carbajal S., Clifford J., Peavey M., Kiguchi K., Itami S., Nickoloff B.J., DiGiovanni J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 2005, 11:43-49.
20. Sano S., Chan K.S., DiGiovanni J. Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases. J. Dermatol. Sci. 2008, 50:1-14.
21. Sano S., Itami S., Takeda K., Tarutani M., Yamaguchi Y., Miura H., Yoshikawa K., Akira S., Takeda J. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 1999, 18:4657-4668.
22. Sashihara T., Sueki N., Ikegami S. An analysis of the effectiveness of heat-killed lactic acid bacteria in alleviating allergic diseases. J. Dairy Sci. 2006, 89:2846-2855.
23. Sawada J., Morita H., Tanaka A., Salminen S., He F., Matsuda H. Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice. Clin. Exp. Allergy 2007, 37:296-303.
24. Shimazu T., Villena J., Tohno M., Fujie H., Hosoya S., Shimosato T., Aso H., Suda Y., Kawai Y., Saito T., Makino S., Ikegami S., Itoh H., Kitazawa H. Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infect. Immun. 2012, 80:276-288.
25. Shimizu N., Dairiki K., Ogawa S., Kaneko T. Dietary whey protein hydrolysate suppresses development of atopic dermatitis-like skin lesions induced by mite antigen in NC/Nga mice. Allergol. Int. 2006, 55:185-189.
26. H2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest 1999, 103:1103-1111.
27. Unno T., Suto H., Yoshiike T., Ogawa H., Ra C. Induction of atopic dermatitis-like skin lesion in NC/Nga mice-The influence of the skin barrier destroying solution to the induction of dermatitis. Arerugi 2001, 50:1152-1162. (in Japanese).
28. Wilson M.S., Taylor M.D., Balic A., Finney C.A., Lamb J.R., Maizels R.M. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J. Exp. Med. 2005, 202:1199-1212.
29. Wüthrich B. Serum IgE in atopic dermatitis: Relationship to severity of cutaneous involvement and course of disease as well as coexistence of atopic respiratory diseases. Clin. Allergy 1978, 8:241-248.